Evidence map›Paper›PMID 19208760›Full record

ArticleJournal of cell science2009

A common trafficking route for GLUT4 in cardiomyocytes in response to insulin, contraction and energy-status signalling.

Daniel J Fazakerley, Scott P Lawrence, Vladimir A Lizunov, Samuel W Cushman, Geoffrey D Holman

Erratum issuedAbstract read
In one paragraph

Article in Journal of cell science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. Intravenous regular insulin is an efficient and safe procedure for obtaining high-quality cardiacJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Heart failure in diabetes.Metabolism: clinical and experimental · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Thirty sweet years of GLUT4.The Journal of biological chemistry · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Daniel J FazakerleyDepartment of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Scott P Lawrence
Vladimir A Lizunov
Samuel W Cushman
Geoffrey D Holman
University of Bath · GBNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · US

Funding

Regulation of Glucose Transport in Muscle CellsZIADK055117 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CUSHMAN, SAMUEL · 2009 to 2013
$964k
Regulation of Glucose Transport in Muscle CellsZ01DK055117 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CUSHMAN, SAMUEL · 2007 to 2008
$715k
British Heart Foundation PG/03/096/15794Intramural NIH HHSMedical Research Council G0300415Medical Research Council G9225018Medical Research Council G9225018(63350)Medical Research Council MR/J003417/1Wellcome Trust 081168
6 · The paper itself

Abstract

A new mouse model has been developed to study the localisation and trafficking of the glucose transporter GLUT4 in muscle. The mouse line has specific expression of a GFP and HA-epitope-tagged version of GLUT4 under the control of a muscle-specific promoter. The exofacial HA-tag has enabled fluorescent labelling of only the GLUT4 exposed at the external surface. A distinction between sarcolemma labelling and transverse-tubule labelling has also been possible because the former compartment is much more accessible to intact anti-HA antibody. By contrast, the Fab fragment of the anti-HA antibody could readily detect GLUT4 at the surface of both the sarcolemma and transverse tubules. Here, we have used this mouse model to examine the route taken by cardiomyocyte GLUT4 as it moves to the limiting external membrane surface of sarcolemma and transverse-tubules in response to insulin, contraction or activators of energy-status signalling, including hypoxia. HA-GLUT4-GFP is largely excluded from the sarcolemma and transverse-tubule membrane of cardiomyocytes under basal conditions, but is similarly trafficked to these membrane surfaces after stimulation with insulin, contraction or hypoxia. Internalisation of sarcolemma GLUT4 has been investigated by pulse-labelling surface GLUT4 with intact anti-HA antibody. At early stages of internalisation, HA-tagged GLUT4 colocalises with clathrin at puncta at the sarcolemma, indicating that in cells returning to a basal state, GLUT4 is removed from external membranes by a clathrin-mediated route. We also observed colocalisation of GLUT4 with clathrin under basal conditions. At later stages of internalisation and at steady state, anti-HA antibody labeled-GLUT4 originating from the sarcolemma was predominantly detected in a peri-nuclear compartment, indistinguishable among the specific initial stimuli. These results taken together imply a common pathway for internalisation of GLUT4, independent of the initial stimulus.

Indexed as

Energy MetabolismAnimalsCells, CulturedClathrinGlucose Transporter Type 4HypoxiaInsulinMaleMiceMice, Inbred C57BLMice, TransgenicMyocardial ContractionMyocytes, CardiacProtein TransportRecombinant Fusion ProteinsSarcolemmaClathrinGlucose Transporter Type 4InsulinRecombinant Fusion Proteins

Identifiers

PMID19208760
PMCPMC2720923
OpenAlexW2136036129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.